Therefore, an in-depth understanding of the relationships between the gut microbiota and the NLRP3 inflammasome, and the identification of related foods or probiotics that regulate intestinal microecological balance, can provide new treatment directions for PMD. This evidence concerns the gene NLRP3 and Pelizeaus-Merzbacher spectrum disorder.